Avance Biosciences

Executive Summary

Avance Biosciences is a Houston-based Contract Research Organization (CRO) and Contract Testing Organization (CTO) that has been providing CGMP and GLP-compliant analytical and bioanalytical services since 2009. The company supports drug development for pharmaceutical and biotech clients by offering expertise in proteomics and diagnostics, enabling faster and more reliable preclinical and clinical testing. With a focus on quality and compliance, Avance Biosciences serves as a critical partner in the drug development ecosystem, particularly for companies seeking to outsource complex analytical work. Although privately held and not a drug developer itself, the company benefits from the growing trend of pharmaceutical outsourcing and the increasing complexity of regulatory requirements. Its established presence in the CRO space positions it for steady revenue growth, though it faces competition from larger, more diversified service providers.

Upcoming Catalysts (preview)

• TBDExpansion of Service Offerings into New Modalities60% success
• TBDStrategic Partnership with a Major Pharmaceutical Company50% success
• TBDRegulatory Accreditation or Certification (e.g., CAP, CLIA)70% success